1. Home
  2. ELAB vs ISPC Comparison

ELAB vs ISPC Comparison

Compare ELAB & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELAB
  • ISPC
  • Stock Information
  • Founded
  • ELAB 2020
  • ISPC 2009
  • Country
  • ELAB United States
  • ISPC United States
  • Employees
  • ELAB N/A
  • ISPC N/A
  • Industry
  • ELAB
  • ISPC Precision Instruments
  • Sector
  • ELAB
  • ISPC Health Care
  • Exchange
  • ELAB Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • ELAB 3.2M
  • ISPC 3.1M
  • IPO Year
  • ELAB 2023
  • ISPC 2021
  • Fundamental
  • Price
  • ELAB $2.28
  • ISPC $1.07
  • Analyst Decision
  • ELAB
  • ISPC
  • Analyst Count
  • ELAB 0
  • ISPC 0
  • Target Price
  • ELAB N/A
  • ISPC N/A
  • AVG Volume (30 Days)
  • ELAB 180.3K
  • ISPC 182.2K
  • Earning Date
  • ELAB 08-13-2025
  • ISPC 08-05-2025
  • Dividend Yield
  • ELAB N/A
  • ISPC N/A
  • EPS Growth
  • ELAB N/A
  • ISPC N/A
  • EPS
  • ELAB N/A
  • ISPC N/A
  • Revenue
  • ELAB N/A
  • ISPC $8,058,631.00
  • Revenue This Year
  • ELAB N/A
  • ISPC $35.93
  • Revenue Next Year
  • ELAB N/A
  • ISPC N/A
  • P/E Ratio
  • ELAB N/A
  • ISPC N/A
  • Revenue Growth
  • ELAB N/A
  • ISPC N/A
  • 52 Week Low
  • ELAB $1.95
  • ISPC $0.86
  • 52 Week High
  • ELAB $660.80
  • ISPC $8.30
  • Technical
  • Relative Strength Index (RSI)
  • ELAB 48.70
  • ISPC 51.15
  • Support Level
  • ELAB $2.20
  • ISPC $0.90
  • Resistance Level
  • ELAB $2.47
  • ISPC $1.14
  • Average True Range (ATR)
  • ELAB 0.21
  • ISPC 0.14
  • MACD
  • ELAB 0.00
  • ISPC 0.01
  • Stochastic Oscillator
  • ELAB 14.08
  • ISPC 49.79

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: